Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Burton

Showing results (151-160 of 203) with videos related to

Pageof 21
Sort By:
Immunity|March 15, 2015
Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergyMagali Noval Rivas, Oliver T Burton, Petra Wise, et al.
The Journal of Clinical Investigation|January 1, 1993
Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cellsN Ferrara, J Winer, T Burton, et al.
AIDS (London, England)|October 18, 2005
Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapyChristopher M Mela, Catherine T Burton, Nesrina Imami, et al.
Scandinavian Journal of Immunology|June 7, 2003
Restoration of human immunodeficiency virus-1-specific responses in patients changing from protease to non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapyA K Sullivan, C T Burton, M R Nelson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2010
Roles for TGF-beta and programmed cell death 1 ligand 1 in regulatory T cell expansion and diabetes suppression by zymosan in nonobese diabetic miceOliver T Burton, Paola Zaccone, Jenny M Phillips, et al.
Clinical and Experimental Immunology|April 16, 2008
Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudyC T Burton, R L Goodall, A Samri, et al.
Clinical and Experimental Immunology|September 17, 2003
Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsivenessG A D Hardy, N Imami, A K Sullivan, et al.
Cell Reports Methods|February 23, 2023
A cross entropy test allows quantitative statistical comparison of t-SNE and UMAP representationsCarlos P Roca, Oliver T Burton, Julika Neumann, et al.
Frontiers in Immunology|July 22, 2022
Allergen-Specific IgA Antibodies Block IgE-Mediated Activation of Mast Cells and BasophilsYasmeen S El Ansari, Cynthia Kanagaratham, Oliver T Burton, et al.
Mucosal Immunology|November 15, 2012
Direct effects of IL-4 on mast cells drive their intestinal expansion and increase susceptibility to anaphylaxis in a murine model of food allergyO T Burton, A R Darling, J S Zhou, et al.
Pageof 21

Showing results (151-160 of 203) with videos related to

Sort By:
Pageof 21
Immunity|March 15, 2015
Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergyMagali Noval Rivas, Oliver T Burton, Petra Wise, et al.
The Journal of Clinical Investigation|January 1, 1993
Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cellsN Ferrara, J Winer, T Burton, et al.
AIDS (London, England)|October 18, 2005
Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapyChristopher M Mela, Catherine T Burton, Nesrina Imami, et al.
Scandinavian Journal of Immunology|June 7, 2003
Restoration of human immunodeficiency virus-1-specific responses in patients changing from protease to non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapyA K Sullivan, C T Burton, M R Nelson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2010
Roles for TGF-beta and programmed cell death 1 ligand 1 in regulatory T cell expansion and diabetes suppression by zymosan in nonobese diabetic miceOliver T Burton, Paola Zaccone, Jenny M Phillips, et al.
Clinical and Experimental Immunology|April 16, 2008
Restoration of anti-tetanus toxoid responses in patients initiating highly active antiretroviral therapy with or without a boost immunization: an INITIO substudyC T Burton, R L Goodall, A Samri, et al.
Clinical and Experimental Immunology|September 17, 2003
Reconstitution of CD4+ T cell responses in HIV-1 infected individuals initiating highly active antiretroviral therapy (HAART) is associated with renewed interleukin-2 production and responsivenessG A D Hardy, N Imami, A K Sullivan, et al.
Cell Reports Methods|February 23, 2023
A cross entropy test allows quantitative statistical comparison of t-SNE and UMAP representationsCarlos P Roca, Oliver T Burton, Julika Neumann, et al.
Frontiers in Immunology|July 22, 2022
Allergen-Specific IgA Antibodies Block IgE-Mediated Activation of Mast Cells and BasophilsYasmeen S El Ansari, Cynthia Kanagaratham, Oliver T Burton, et al.
Mucosal Immunology|November 15, 2012
Direct effects of IL-4 on mast cells drive their intestinal expansion and increase susceptibility to anaphylaxis in a murine model of food allergyO T Burton, A R Darling, J S Zhou, et al.
Pageof 21